Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

301 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
How to Transition from Single-Gene Pharmacogenetic Testing to Preemptive Panel-Based Testing: A Tutorial.
Marrero RJ, Cicali EJ, Arwood MJ, Eddy E, DeRemer D, Ramnaraign BH, Daily KC, Jones D Jr, Cook KJ, Cavallari LH, Wiisanen Weitzel K, Langaee T, Newsom KJ, Starostik P, Clare-Salzer MJ, Johnson JA, George TJ, Cooper-DeHoff RM. Marrero RJ, et al. Among authors: george tj. Clin Pharmacol Ther. 2020 Sep;108(3):557-565. doi: 10.1002/cpt.1912. Epub 2020 Jul 6. Clin Pharmacol Ther. 2020. PMID: 32460360 Free PMC article.
Discordant HER2 expression and response to neoadjuvant chemoradiotherapy in esophagogastric adenocarcinoma.
Chan E, Duckworth LV, Alkhasawneh A, Toro TZ, Lu X, Ben-David K, Hughes SJ, Rossidis G, Zlotecki R, Lightsey J, Daily KC, Dang L, Allegra CJ, King B, George TJ Jr. Chan E, et al. Among authors: george tj jr. J Gastrointest Oncol. 2016 Apr;7(2):173-80. doi: 10.3978/j.issn.2078-6891.2015.071. J Gastrointest Oncol. 2016. PMID: 27034783 Free PMC article.
Stereotactic body radiation therapy for oligoprogression of metastatic disease from gastrointestinal cancers: A novel approach to extend chemotherapy efficacy.
Wray J, Hawamdeh RF, Hasija N, Dagan R, Yeung AR, Lightsey JL, Okunieff P, Daily KC, George TJ, Zlotecki RA, Trevino J, Dang LH. Wray J, et al. Among authors: george tj. Oncol Lett. 2017 Mar;13(3):1087-1094. doi: 10.3892/ol.2016.5540. Epub 2016 Dec 27. Oncol Lett. 2017. PMID: 28454218 Free PMC article.
Synthetic lethality in malignant pleural mesothelioma with PARP1 inhibition.
Srinivasan G, Sidhu GS, Williamson EA, Jaiswal AS, Najmunnisa N, Wilcoxen K, Jones D, George TJ Jr, Hromas R. Srinivasan G, et al. Among authors: george tj jr. Cancer Chemother Pharmacol. 2017 Oct;80(4):861-867. doi: 10.1007/s00280-017-3401-y. Epub 2017 Jul 29. Cancer Chemother Pharmacol. 2017. PMID: 28756516 Free PMC article.
Design and rational for the precision medicine guided treatment for cancer pain pragmatic clinical trial.
Mosley SA, Hicks JK, Portman DG, Donovan KA, Gopalan P, Schmit J, Starr J, Silver N, Gong Y, Langaee T, Clare-Salzler M, Starostik P, Chang YD, Rajasekhara S, Smith JE, Soares HP, George TJ Jr, McLeod HL, Cavallari LH. Mosley SA, et al. Among authors: george tj jr. Contemp Clin Trials. 2018 May;68:7-13. doi: 10.1016/j.cct.2018.03.001. Epub 2018 Mar 10. Contemp Clin Trials. 2018. PMID: 29535047 Free PMC article.
Immunotherapy Management in Special Cancer Patient Populations.
Ramnaraign BH, Chatzkel JA, Al-Mansour ZA, Rogers S, Jones D, DeRemer D, George TJ. Ramnaraign BH, et al. Among authors: george tj. JCO Oncol Pract. 2021 May;17(5):240-245. doi: 10.1200/OP.20.00996. Epub 2021 Mar 12. JCO Oncol Pract. 2021. PMID: 33710933 Review.
301 results